All In MedTech

Device Trial Radar · NCT00519961

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Last checked: Nov 20, 2026Latest source record: Mar 16, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

1,800

Planned (sponsor's estimate)

Start

Feb 2007

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
Hoffmann-La RocheNot on our public-company list
Sponsor type
Industry
First posted
Aug 23, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.

Conditions

  • Peripheral Vascular Disease

Interventions

  • Elecsys®proBNPDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Collection of 30-day and 1-year postoperative cardiac eventsTime frame: 30-day and 1-year postoperation

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Site not named

    Dublin, Ireland · Recruiting

  • Site not named

    Rotterdam, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.